Skip to content

Alcohol Consumption and Circulating Metabolites

Circulating Metabolites Associated With Alcohol Intake in the European Prospective Investigation Into Cancer and Nutrition Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03402568
Enrollment
2974
Registered
2018-01-18
Start date
2012-10-24
Completion date
2016-10-26
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No Condition, Focus: Metabolites of Alcohol Consumption

Keywords

alcohol, targeted metabolomics, lipid metabolites, amino acids, acylcarnitines

Brief summary

Alcohol consumption is a risk factor for numerous health conditions and an important cause of death. Identifying metabolites associated with alcohol consumption may provide insights into the metabolic pathways through which alcohol may affect human health. The objective of this study is to investigate associations of alcohol consumption with circulating concentrations of 123 metabolites including amino acids, acylcarnitines, hexoses, biogenic amines, phosphatidylcholines, and sphingomyelins. For this purpose, the investigators use data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study and applied a discovery and replication approach.

Detailed description

This study used data from 2,974 control participants from four case-control studies on colorectal (n=491), hepatobiliary (n=327), kidney (n=635), and prostate cancer (n=1,521) nested in the EPIC cohort, for which targeted metabolomics data had been acquired. Alcohol consumption at recruitment was self-reported through dietary questionnaires. Metabolite concentrations were measured by tandem mass spectrometry using the BIOCRATES AbsoluteIDQTM p180 kit. Data were randomly divided into discovery (2/3) and replication (1/3) sets. Multivariable linear regression models were used to evaluate confounder-adjusted associations of ln-transformed alcohol consumption with Z-standardized ln-transformed residual metabolite concentrations. Metabolites significantly related to alcohol intake in the discovery set (FDR q-value\<0.05) were further tested in the replication set (Bonferroni-corrected p-value\<0.05). Of the 72 metabolites significantly related to alcohol intake in the discovery set, 34 metabolites were also significant in the replication analysis, including three acylcarnitines, the amino acid citrulline, four lysophosphatidylcholines, 13 diacylphosphatidylcholines, seven acyl-alkylphosphatidylcholines, and six sphingomyelins. Associations with acylcarnitines and phosphatidylcholines were generally positive, while mostly inverse associations were observed with citrulline and sphingomyelins. This study adds novel knowledge regarding circulating metabolites associated with alcohol consumption, and provides leads for further studies into the underlying biological mechanisms. A better understanding of metabolic pathways affected by alcohol consumption may contribute to the development of mechanism-tailored intervention strategies to prevent and treat alcohol-related conditions. Furthermore, it may help to identify biomarkers of alcohol consumption facilitating early preventive strategies in individuals at-risk for developing alcohol-related morbidities.

Interventions

None listed

Sponsors

International Agency for Research on Cancer
Lead SponsorOTHER
Maastricht University
CollaboratorOTHER
Imperial College London
CollaboratorOTHER
Danish Cancer Society
CollaboratorOTHER
University of Aarhus
CollaboratorOTHER
Centre for Research in Epidemiology and Population Health (CESP)
CollaboratorOTHER
Gustave Roussy, Cancer Campus, Grand Paris
CollaboratorOTHER
German Cancer Research Center
CollaboratorOTHER
German Institute of Human Nutrition
CollaboratorOTHER
Hellenic Health Foundation
CollaboratorOTHER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
CollaboratorOTHER
ISPO Cancer Prevention and Research Institute
CollaboratorUNKNOWN
Federico II University
CollaboratorOTHER
HuGeF Foundation
CollaboratorUNKNOWN
Azienda Sanitaria Provinciale Ragusa
CollaboratorOTHER
University of Tromso
CollaboratorOTHER
Institut Català d'Oncologia
CollaboratorOTHER
Ministry of Health - Government of the Principality of Asturias
CollaboratorOTHER_GOV
Andalusian School of Public Health
CollaboratorOTHER_GOV
Universidad de Murcia
CollaboratorOTHER
Instituto de Salud Pública Gobierno de Navarra
CollaboratorUNKNOWN
Subdirección de Salud Pública de Gipuzkoa
CollaboratorUNKNOWN
Skane University Hospital
CollaboratorOTHER
Umeå University
CollaboratorOTHER
MORGEN-EPIC, Bilthoven
CollaboratorUNKNOWN
Prospect-EPIC, Utrecht
CollaboratorUNKNOWN
University of Oxford
CollaboratorOTHER
University of Cambridge
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

(for EPIC): * Aged 30-70 * Healthy volunteers residing within defined geographical areas (where study centers are located). Different settings by centre; mostly general population with some exceptions: women of a health insurance company for teachers and school workers (France), women attending breast cancer screening (Utrecht-The Netherlands, and Florence-Italy), mainly blood donors (most centers in Italy and Spain) and a cohort consisting predominantly of vegetarians (the 'health-conscious' group in Oxford, UK).

Exclusion criteria

(for this study): * Individuals without metabolomics data * Individuals without data on alcohol consumption at recruitment

Design outcomes

Primary

MeasureTime frameDescription
Circulating metabolite concentrationsLaboratory analyses performed between Oct 2012-Oct 2016Blood concentrations of 123 metabolites including amino acids, acylcarnitines, hexoses, biogenic amines, phosphatidylcholines, and sphingomyelins (BIOCRATES AbsoluteIDQTM p180 kit).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026